New combo attack on Tough-to-Treat leukemia
NCT ID NCT07301424
Summary
This study is testing a new way to treat a fast-growing blood cancer called B-ALL that has a specific genetic change (BCR-ABL). Researchers want to see if giving an immune-boosting injection under the skin (blinatumomab) along with a daily pill (ponatinib) is effective and safe for adults who haven't had treatment yet. The goal is to deeply reduce or eliminate cancer cells and control the disease long-term.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PHILADELPHIA CHROMOSOME-POSITIVE (PH+) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Alberta
Edmonton, Alberta, T6G 2G3, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.